Previous close | 1.1300 |
Open | 0.9206 |
Bid | 0.9000 x 1300 |
Ask | 0.9050 x 1300 |
Day's range | 0.7621 - 0.9395 |
52-week range | 0.7620 - 9.7500 |
Volume | |
Avg. volume | 8,330,803 |
Market cap | 480.643M |
Beta (5Y monthly) | 0.08 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.7700 |
Earnings date | 01 Mar 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 3.62 |
Cano Health ( NYSE:CANO ) Full Year 2022 Results Key Financial Results Revenue: US$2.74b (up 70% from FY 2021). Net...
Cano Health, Inc. (CANO) delivered earnings and revenue surprises of 280% and 3.83%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Both Roku (NASDAQ: ROKU) and Cano Health (NYSE: CANO) are up more than 30%. Roku has been red hot in 2023, up an incredible 62% already. A big reason for Roku's struggles last year is that the company was unprofitable and the ad market simply wasn't strong.